Australia markets open in 3 hours 53 minutes

Leap Therapeutics, Inc. (5MC.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
2.22000.0000 (0.00%)
At close: 08:23AM CEST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-53,371
-81,414
-54,596
-40,587
-27,514
-
Depreciation & amortisation
16
15
16
29
34
-
Stock-based compensation
5,066
5,128
5,180
3,482
2,617
-
Change in working capital
1,536
2,511
-651
1,013
-990
-
Other working capital
-46,569
-43,753
-49,044
-35,157
-25,957
-
Other non-cash items
412
29,994
399
527
634
-
Net cash provided by operating activities
-46,569
-43,753
-49,044
-35,157
-25,957
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-
-
-
-100
Other investing activities
-
-1,393
-
-
-
-
Net cash used for investing activities
-348
48,969
0
0
25
-
Cash flows from financing activities
Common stock issued
-
-
0
97,222
48,518
15,254
Common stock repurchased
-
-1
0
-
-
-
Other financing activities
-
-
-210
-184
-1,906
-437
Net cash used provided by (used for) financing activities
28
-30
-210
98,035
73,997
-
Net change in cash
-47,117
5,143
-49,416
62,845
48,180
-
Cash at beginning of period
102,038
65,500
114,916
52,071
3,891
-
Cash at end of period
55,149
70,643
65,500
114,916
52,071
-
Free cash flow
Operating cash flow
-46,569
-43,753
-49,044
-35,157
-25,957
-
Capital expenditure
-
-
-
-
-
-100
Free cash flow
-46,569
-43,753
-49,044
-35,157
-25,957
-